Prism Medico & Pharmacy Ltd. Press Release Nov 14 2025

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 14th November, 2025) which commenced at 03:30 P.M. and concluded at 06:00 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September, 2025 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.Thanking You.